Indonesia seeks to launch home-grown Covid-19 vaccine in third quarter


A healthcare worker inoculates a woman with a dose of the Pfizer vaccine against the Covid-19 during a mass vaccination at a shopping mall in Jakarta. Indonesia has aimed to develop and manufacture its own vaccines domestically since the start of the pandemic. - Reuters

JAKARTA, Feb 20 (Jakarta Post/ANN): Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Indonesia , Covid-19 , Home Grown , Vaccine , Third Quarter , 2022

Next In Aseanplus News

Women farmers could unlock the future of food security in Asia and the Pacific: Opinion
India's Wipro slips as weak forecast deepens growth concerns
China says it is willing to work with Vietnam on railways
Foreign investors flee Thailand as Iran conflict, energy shock dash hope for economic revival
‘Korean Coachella’: K-pop agencies Hybe, JYP, SM and YG to launch music festival
Myanmar to free more than 4,000 prisoners in amnesty
Rupiah hits record low against Singapore dollar, threatening Indonesian arrivals and trade
Wan Saiful open to PAS membership
Australian soldier accused of war crimes in Afghanistan granted bail
New Zealand PM says he has party's full support after reports of leadership challenge

Others Also Read